Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ANZU NYSE:APT NYSE:MLSS NASDAQ:RNXT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeANZUAnzu Special Acquisition Corp I$0.66-3.0%$1.76$5.21▼$11.72$9.90M0.03109,623 shs244,040 shsAPTAlpha Pro Tech$5.14-1.3%$5.48$4.34▼$7.50$52.52M0.8765,983 shs14,373 shsMLSSMilestone Scientific$0.41-3.1%$0.37$0.22▼$0.68$36.44M1.051.08 million shs20,209 shsRNXTRenovoRx$0.88+1.6%$0.90$0.70▼$1.45$38.91M0.99202,055 shs117,389 shs7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceANZUAnzu Special Acquisition Corp I0.00%0.00%0.00%0.00%-58.82%APTAlpha Pro Tech+0.97%+3.58%-4.05%+13.51%+9.68%MLSSMilestone Scientific-2.72%+7.76%+14.49%+34.87%-31.26%RNXTRenovoRx-0.18%-5.44%-6.12%-9.01%-33.56%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeANZUAnzu Special Acquisition Corp I$0.66-3.0%$1.76$5.21▼$11.72$9.90M0.03109,623 shs244,040 shsAPTAlpha Pro Tech$5.14-1.3%$5.48$4.34▼$7.50$52.52M0.8765,983 shs14,373 shsMLSSMilestone Scientific$0.41-3.1%$0.37$0.22▼$0.68$36.44M1.051.08 million shs20,209 shsRNXTRenovoRx$0.88+1.6%$0.90$0.70▼$1.45$38.91M0.99202,055 shs117,389 shs7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceANZUAnzu Special Acquisition Corp I0.00%0.00%0.00%0.00%-58.82%APTAlpha Pro Tech+0.97%+3.58%-4.05%+13.51%+9.68%MLSSMilestone Scientific-2.72%+7.76%+14.49%+34.87%-31.26%RNXTRenovoRx-0.18%-5.44%-6.12%-9.01%-33.56%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceANZUAnzu Special Acquisition Corp I 0.00N/AN/AN/AAPTAlpha Pro Tech 0.00N/AN/AN/AMLSSMilestone Scientific 3.00Buy$1.00142.72% UpsideRNXTRenovoRx 2.75Moderate Buy$8.50868.55% UpsideCurrent Analyst Ratings BreakdownLatest ANZU, MLSS, APT, and RNXT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/17/2026RNXTRenovoRx Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)6/29/2026RNXTRenovoRx Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)6/8/2026RNXTRenovoRx Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)6/1/2026RNXTRenovoRx Ascendiant Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$13.50 ➝ $14.00(Data available from 7/21/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookANZUAnzu Special Acquisition Corp IN/AN/A$0.18 per share3.74($1.69) per shareN/AAPTAlpha Pro Tech$59.91M0.88$0.40 per share12.80$5.29 per share0.97MLSSMilestone Scientific$8.90M4.09N/AN/A$0.11 per share3.75RNXTRenovoRx$1.12M35.30N/AN/A$0.15 per share5.85Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateANZUAnzu Special Acquisition Corp I$19.23MN/AN/AN/AN/AN/A-17.33%1.37%N/AAPTAlpha Pro Tech$4.19M$0.3513.89N/AN/A6.99%6.70%5.76%N/AMLSSMilestone Scientific-$6.93M-$0.05N/AN/AN/A-52.01%-60.26%-40.23%N/ARNXTRenovoRx-$11.17M-$0.33N/AN/AN/A-823.98%-135.03%-101.92%8/13/2026 (Estimated)Latest ANZU, MLSS, APT, and RNXT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/13/2026Q2 2026RNXTRenovoRx-$0.08N/AN/AN/A$0.70 millionN/A5/14/2026Q1 2026RNXTRenovoRx-$0.08-$0.08N/A-$0.09$0.47 million$0.56 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthANZUAnzu Special Acquisition Corp IN/AN/AN/AN/AN/AAPTAlpha Pro TechN/AN/AN/AN/AN/AMLSSMilestone ScientificN/AN/AN/AN/AN/ARNXTRenovoRxN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioANZUAnzu Special Acquisition Corp IN/A0.040.04APTAlpha Pro TechN/A19.0011.21MLSSMilestone ScientificN/A2.851.86RNXTRenovoRxN/A7.156.95Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipANZUAnzu Special Acquisition Corp I27.26%APTAlpha Pro Tech22.69%MLSSMilestone Scientific5.79%RNXTRenovoRx3.10%Insider OwnershipCompanyInsider OwnershipANZUAnzu Special Acquisition Corp I0.67%APTAlpha Pro Tech16.20%MLSSMilestone Scientific9.22%RNXTRenovoRx9.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableANZUAnzu Special Acquisition Corp I314.94 million14.84 millionNot OptionableAPTAlpha Pro Tech12010.22 million9.46 millionOptionableMLSSMilestone Scientific3088.45 million58.61 millionOptionableRNXTRenovoRx645.05 million40.82 millionNot OptionableANZU, MLSS, APT, and RNXT HeadlinesRecent News About These CompaniesRenovoRx (NASDAQ:RNXT) Upgraded by Wall Street Zen to Sell RatingJuly 18 at 1:30 AM | americanbankingnews.comRenovoRx Stock Short Interest Report | NASDAQ:RNXT | BenzingaJuly 7, 2026 | benzinga.comRenovoRx Stockholders Approve Directors and Equity PlanJune 30, 2026 | tipranks.comRenovoRx, Inc. (RNXT) Presents at IAccess Alpha Virtual Best Ideas Summer Investment Conference 2026 TranscriptJune 23, 2026 | seekingalpha.comRenovoRx Highlights Peer-Reviewed Publication Supporting Intra-Arterial Gemcitabine Delivery Via TAMP™ in Locally Advanced Pancreatic CancerJune 11, 2026 | globenewswire.comAscendiant Remains a Buy on RenovoRx (RNXT)June 5, 2026 | theglobeandmail.comRenovoRx CEO, Shaun Bagai, to Present at the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2026 on June 23rdJune 4, 2026 | globenewswire.comRenovoRx, Inc.: RenovoRx Announces FDA Orphan Drug Designation Granted: Oxaliplatin for the Treatment of Pancreatic CancerMay 28, 2026 | finanznachrichten.deRenovoRx Announces FDA Orphan Drug Designation Granted: Oxaliplatin for the Treatment of Pancreatic CancerMay 28, 2026 | globenewswire.comRenovoRx Announces Promising Pharmacokinetic Data Using the TAMP™ Platform Presented at the 2026 ASCO Annual MeetingMay 26, 2026 | globenewswire.comMark Voll Buys 25,000 Shares of RenovoRx (NASDAQ:RNXT) StockMay 22, 2026 | insidertrades.comRenovoRx (RNXT) Q1 2026 Earnings TranscriptMay 19, 2026 | fool.comRenovoRx to Present at the Alliance Global Partners Virtual Annual Healthcare Company Showcase on May 20thMay 19, 2026 | globenewswire.comShaun Bagai, CEO of Renovorx, buys $0 of RNXT stockMay 18, 2026 | investing.comRenovoRx Inc (RNXT) Q1 2026 Earnings Call Highlights: Record Revenue and Strategic ExpansionMay 15, 2026 | finance.yahoo.comRenovoRx, Inc. (RNXT) Reports Q1 Loss, Tops Revenue EstimatesMay 14, 2026 | zacks.comRenovoRx Reports Record First Quarter 2026: Increasing Revenue by 136% Quarter-over-QuarterMay 14, 2026 | finance.yahoo.comRenovoRx Inc (RNXT) Q1 2026 Earnings Report Preview: What To ExpectMay 14, 2026 | finance.yahoo.comRenovoRx, Inc. (RNXT) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseMay 7, 2026 | zacks.comAnalysts Offer Insights on Healthcare Companies: RenovoRx (RNXT) and Protara Therapeutics (TARA)May 1, 2026 | theglobeandmail.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSK Hynix’s Nasdaq Listing Could Reset the AI Memory TradeBy Thomas Hughes | July 7, 20265 Tech Stocks to Buy on the July PullbackBy Thomas Hughes | June 29, 2026Micron’s Sudden Plunge May Be an AI Buying ChanceBy Jeffrey Neal Johnson | June 23, 2026onsemi: What the Market Gets Wrong, You Can Get RightBy Thomas Hughes | June 29, 2026Palantir's CEO Just Called Out OpenAI and AnthropicBy Chris Markoch | July 7, 2026ANZU, MLSS, APT, and RNXT Company DescriptionsAnzu Special Acquisition Corp I NASDAQ:ANZUAnzu Special Acquisition Corp I does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of industrial applications. Anzu Special Acquisition Corp I was incorporated in 2020 and is based in Tampa, Florida. Anzu Special Acquisition Corp I operates as a subsidiary of Anzu SPAC GP I LLC.Alpha Pro Tech NYSE:APT$5.14 -0.07 (-1.34%) Closing price 04:00 PM EasternExtended Trading$5.22 +0.08 (+1.46%) As of 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Alpha Pro Tech, Ltd., together with its subsidiaries, develops, manufactures, and markets a range of disposable protective apparel, infection control, and building supply products in the United States and internationally. The company operates through Disposable Protective Apparel and Building Supply segments. The Disposable Protective Apparel segment provides shoe covers, bouffant caps, coveralls, frocks, lab coats, and gowns, hoods, as well as face masks and shields. The Building Supply segment offers construction weatherization products, such as housewrap and housewrap accessories, including window and door flashing, and seam tape, synthetic roof underlayment, and self-adhered roof underlayment, as well as other woven material. The company markets its products under the Alpha Pro Tech brand name, as well as under private labels. Its products are used primarily in cleanrooms; industrial safety manufacturing environments; health care facilities, such as hospitals, laboratories, and dental offices; building and re-roofing sites. The company distributes its products through a network of purchasing groups, distributors, and independent sales representatives, as well as through its sales and marketing force. Alpha Pro Tech, Ltd. was founded in 1983 and is headquartered in Markham, Canada.Milestone Scientific NYSE:MLSS$0.41 -0.01 (-3.08%) Closing price 04:00 PM EasternExtended Trading$0.42 +0.01 (+1.70%) As of 06:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. In addition, the company offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. Further, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Additionally, the company offers company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.RenovoRx NASDAQ:RNXT$0.88 +0.01 (+1.61%) Closing price 04:00 PM EasternExtended Trading$0.88 +0.00 (+0.05%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing proprietary targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is RenovoGem, an oncology drug-device combination product, consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. The company has a research collaboration with Imugene Limited to deliver oncolytic virus therapy for the treatment of difficult-to-access tumors. RenovoRx, Inc. was founded in 2009 and is headquartered in Los Altos, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 3M's Redemption Arc: Can Q2 Earnings Change the Narrative? Alphabet Is Planning a New AI Chip. Here's Why It Matters Ahead of Earnings 3 Photonics Companies Making Quantum Tech Possible Confidence Is Back, But Earnings Show the Consumer Is Being Picky Industrial and Utility Giants Boost Dividends as Data Center Tailwinds Build IREN’s $2.8 Billion AI Contract Haul Changes the Stock’s Story AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off 2 ETFs to Access the World's Best-Performing Stock Markets In 2026 Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
